All Posts By


Q&A with Jon Hunt of Bardy Diagnostics

By | CEO Spotlight
Screen Shot 2017-03-23 at 2.56.06 PMJon Hunt is the President and CEO of Bardy Diagnostics  Prior to Bardy, Jon spent 11 years as the Vice President of Clinical & Regulatory Affairs with Cameron Health, Inc. (acquired by Boston Scientific Corporation in 2012). He spent the 10 years prior with Cardiac Pacemakers, Inc., St. Jude Medical and Cardiac Pathways Corporation. Jon began his career with Cardiac Pacemakers, Inc. (now Boston Scientific Corporation) as the Director of Clinical Programs; he subsequently held positions at St. Jude Medical in Clinical Affairs and as the Business Unit Director for the Cardiac Rhythm Management division for Europe, the Middle East, and Africa. Jon has extensive experience providing key support to cardiac electrophysiologists around the world to ensure that they, and their patients, implement new technologies safely and effectively. Read More

ContinuumRX & Inova Health System Launch JV

By | News

ContinuumRX & Inova Health System have formed a joint healthcare venture aimed at supplying home infusion and specialty pharmacy services to patients in northern Virginia and other nearby areas. Patients will receive services beginning this fall.  Read More

Redefining Payer-Provider Collaboration

By | White Papers

As legislators continue to debate the role of the federal government in administering health care, the need for enhanced coordination between payers and providers has never been more acute. In the last five years, we have seen the most progressive hospitals and health plans enter into partnerships for mutually- beneficial gains. Challenging what was once an openly adversarial relationship, these innovative players are collaborating to share risk, lower cost, and seize market share. Whatever the end result of reform, Health Enterprise Partners contends that the line between payers and providers will continue to blur.
Read More

Steve Lefar Interview

By | CEO Spotlight

Steve Lefar is the CEO of Applied Pathways. Steve was formerly the President and CEO of Sg2, a market leader in providing analytics to providers which was acquired by MedAssets in 2015. Prior to Sg2, he was the President of MediRegs, a pioneer in SAAS applications and content for the healthcare compliance space that was acquired by WoltersKluwer. He currently is a Board Member of Enlitic and an Advisor to Evive Health. Steve also sits on the Board of the Juvenile Diabetes Foundation of Chicago, the Aptakisic-Tripp School District, and on the editorial board of the Society of Corporate Compliance and Ethics. Read More

Catapult Health Raises $10 Million in Series B Funding

By | News

Catapult Health announced the completion of a $10M Series B financing which includes a significant investment by a new partner, UCHealth. Catapult Health’s existing investors also participated in the round, including founders Deborah and David Michel, Chief Technology Officer, Jeffrey O. Smith, Ph.D., and Series A investor Health Enterprise Partners. The company will use the funds to accelerate its rapid national customer growth and expand its team of board certified nurse practitioners who conduct Catapult’s onsite health evaluations. Read More